Solventum presently has a consensus target price of $79.86, suggesting a potential upside of 5.04%. As a group, “Surgical & medical instruments” companies have a potential upside of 33.22%.

Solventum (NYSE:SOLV – Get Free Report) is one of 238 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals?We will compare Solventum to ...

Maplewood, Minnesota-based Solventum Corporation (SOLV) is a healthcare company specializing in developing, manufacturing, and commercializing solutions to address critical customer and patient needs.

Shares of Solventum Corp. SOLV advanced 1.73% to $76.04 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.55% to 5,611.85 ...

Solventum Corporation SOLV partnered with SprintRay to introduce a groundbreaking solution for digital dentistry, enabling high-quality, same-day dental restorations. This innovative partnership ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Our purpose is to create financially ...

STLD plans initially were created to fill temporary insurance gaps that might occur as a person undergoes some sort of life change, such as switching jobs, researchers said in background notes.